Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment
暂无分享,去创建一个
Y. Imai | N. Hiramatsu | K. Ohkawa | T. Kodama | Ryoko Yamada | H. Hikita | R. Sakamori | T. Tatsumi | T. Takehara | Ayako Urabe | Yuki Tahata | H. Hagiwara | M. Oshita